Clinical Trials Directory

Trials / Unknown

UnknownNCT04469101

A Study on the Effect of Position on Walking Labour Epidural Efficacy

Which Position is Best: A Randomized Clinical Trial on the Effect That Position Has on Walking Labour Epidural Analgesia

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
216 (estimated)
Sponsor
University of Saskatchewan · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Accepted

Summary

This study is being done to better understand how patient positioning can affect pain relief after an epidural. In addition to pain, the investigators will assess how position affects epidural spread, and its effects on maternal blood pressure and fetal heart rate.

Detailed description

Epidurals will be placed with parturients in the standard sitting position. An epidural catheter will be placed to a depth of 5 cm into the epidural space. After placement, parturients will be randomized to one of the four position groups (left uterine displacement, left lateral, right lateral, or seated upright). After successful positioning, a series of 5 cc bolus doses of 0.08% ropivacaine with 2 mcg per cc of fentanyl will be injected through the epidural catheter in 5 minute intervals for a total volume of 20 cc. After the initial loading dose of epidural solution has been injected in the first 20 minutes post-insertion, the patient will be able to return to whatever position they are most comfortable with. The parturient will be asked to rate their pain on a verbal pain scale of between 0 and 10 at the peak of their contraction at three time intervals. The spread of the blockade will be assessed with ice applied along both the left and right mid-clavicular lines. Maternal blood pressure will be measured on the upper arm in all patients as per nursing protocol. Fetal heart rate will be monitored intermittently with Doppler ultrasound as per nursing protocol.

Conditions

Interventions

TypeNameDescription
PROCEDURELumbar EpiduralParturients will have an epidural placed in the upright seated position as per institution standard. After epidural placement, they will be positioned as per their randomization. They will then have a total of 20 cc of epidural solution (0.08% ropivacaine with 2 mcg per cc of fentanyl) injected into the epidural in boluses of 5 cc every 5 minutes.

Timeline

Start date
2021-05-31
Primary completion
2022-07-01
Completion
2022-10-01
First posted
2020-07-13
Last updated
2021-10-18

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT04469101. Inclusion in this directory is not an endorsement.